Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (8)
  • 2025 (85)
  • 2024 (109)
  • 2023 (101)
  • 2022 (60)
  • 2021 (32)
  • 2020 (8)
  • 2019 (2)

Subject

  • Drug Trafficking (4103)
  • Synthetic drugs (1097)
  • Guns/Weapons (1009)
  • OCDETF/Task Force (817)
  • Fake Pills (669)
  • Arrests/Convictions - Major (623)
  • Guilty Plea (540)
  • Seizures (Drugs/Property) (473)
  • Prescription Drugs (370)
  • Overdose (324)
  • Major Law Enforcement Operation (274)
  • Take Back Day (246)
  • Task Forces/Task Force Officers (235)
  • Pharmaceuticals/Pharmacists/Physicians (226)
  • Money Laundering (207)
  • Gangs (199)
  • Outreach/Drug Prevention (185)
  • One Pill Can Kill (113)
  • HIDTA (104)
  • Press Conferences (68)
  • Narcoterrorism (54)
  • Prevention/Education - DEA websites GSAD, JTT etc (53)
  • Extraditions (51)
  • Public and Media Affairs - also see Congressional Affairs (51)
  • Dark Web- Internet Trafficking (29)
  • Asset Forfeiture (28)
  • International/Foreign Operations (28)
  • Red Ribbon (27)
  • Counterfeit Pills (25)
  • Fentanyl Free America (24)
  • Congressional Affairs (15)
  • Terrorism (14)
  • Other (11)
  • Campaigns (10)
  • Intergovernmental Affairs (9)
  • Critical Incident (7)
  • Intelligence Division - Intelligence Products (5)
  • Scam Calls (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Diversion Division (250)
  • Fentanyl Awareness (158)

Drug Name

  • Fentanyl (111)
  • Opioids (48)
  • Oxycodone (38)
  • Methamphetamine (19)
  • Hydromorphone (15)
  • Synthetic Opioids (15)
  • Cocaine (10)
  • Benzodiazepines (8)
  • Heroin (8)
  • Morphine (7)
  • Marijuana (Cannabis) (4)
  • Amphetamines (3)
  • Methadone (3)
  • Steroids (3)
  • Ketamine (1)
  • Marijuana Concentrates (1)
  • Xylazine (1)

Field Division

  • Houston (43)
  • Washington, DC (41)
  • New England (36)
  • Seattle (30)
  • New York (29)
  • Omaha (23)
  • Atlanta (19)
  • Chicago (19)
  • New Jersey (17)
  • Rocky Mountain (17)
  • Sede (17)
  • Louisville (16)
  • Miami (16)
  • New Orleans (15)
  • St. Louis (14)
  • Los Angeles (13)
  • El Paso (11)
  • Phoenix (9)
  • San Francisco (9)
  • Dallas (5)
  • San Diego (4)
  • Detroit (1)
Clear All Results
405 Results - Showing 251 to 260
PRESS RELEASE

Consent Decree Approved Among the U.S. and Cumberland, M.D. based Pharmacy and Pharmacist

Baltimore, Maryland - U.S. District Judge Lydia K. Griggsby approved the United States’ consent decree with John A. Beckman, a Cumberland, Maryland based pharmacist, and Beckman’s Greene Street Pharmacy, Inc. (“Beckman’s Pharmacy”), resolving the United States’ civil allegations that Beckman and Beckman’s Pharmacy violated the Controlled Substances Act (“CSA”) in...
PRESS RELEASE

Boise Nurse Practitioner and Patient/Medical Assistant Charged with Conspiracy to Distribute Opioids

BOISE – U.S. Attorney Josh Hurwit announced criminal charges against two defendants today as part of the Department of Justice’s 2023 National Health Care Fraud Enforcement Action. This two-week nationwide law enforcement action resulted in criminal charges against 78 defendants for their alleged participation in health care fraud and opioid...
PRESS RELEASE

DEA Albuquerque Office Partners with Bernalillo County to Host Free Training for Employers

Albuquerque, N.M. – As part of Operation Engage, DEA Albuquerque has partnered with Bernalillo County to host a free CADCA training for employers seeking to address problematic substance use and misuse in the workplace. The 90-minute training will discuss how problematic substance use impacts businesses and their employees, how to...
PRESS RELEASE

CVS To Pay $70,000 To Resolve Allegations That It Filled Fake Prescriptions

CONCORD, N.H. – CVS has agreed to pay $70,000 to resolve allegations that it violated the Controlled Substances Act at CVS stores in New Hampshire, U.S. Attorney Jane E. Young announces. “Pharmacies have a legal responsibility to ensure that controlled substances are dispensed only pursuant to valid prescriptions,” said United...
PRESS RELEASE

Fourth Circuit Upholds Former Tabor City Doctor’s Conviction for Operating a Pill Mill

NEW BERN, N.C. – A three-judge panel from the Fourth Circuit Court of Appeals issued a unanimous, published opinion affirming former physician Jong Whan Kim’s conviction and sentence for operating a pill mill in Tabor City. The Fourth Circuit’s decision was the first published opinion by the Court upholding a...
PRESS RELEASE

Three Chinese Chemical Manufacturing Companies and Five Employees Charged with Conspiring to Manufacture Fentanyl

Brooklyn, NY - Earlier today, at the federal courthouse in Brooklyn, two indictments were unsealed that detail criminal conspiracies by companies and employees based in China to manufacture and distribute fentanyl in the United States. This prosecution is among the first ever in the United States to charge Chinese chemical...
PRESS RELEASE

Wilmington Doctor to Pay $170,000 to Resolve Allegations of Unlawful Prescribing of Opioids

WILMINGTON, N.C. – Dr. Mark S.T. Armitage, a physician practicing with Pelican Family Medicine in Wilmington, North Carolina, agreed to pay $170,000 to resolve alleged violations of the Controlled Substances Act. Dr. Armitage, who previously surrendered his Drug Enforcement Administration (DEA) registration to prescribe controlled substances, further agreed not to...
PRESS RELEASE

Cheshire Medical Center to Pay $2 Million to Settle Allegations of Controlled Substances Act Violations

CONCORD, N.H. – U.S. Attorney Jane E. Young announces today that Cheshire Medical Center (CMC) in Keene will pay $2 million to resolve allegations that it violated the Controlled Substances Act (CSA) by failing to keep accurate records of controlled substances, including opioids. “Cheshire Medical Center’s failure to fulfill its...
PRESS RELEASE

Catskill Pharmacy Pays $65,000 to Resolve Controlled Substances Act Allegations

ALBANY, NEW YORK – Greene Pharma LLC, dba Greene Medical Arts Pharmacy (Greene Pharma), a pharmacy in Catskill, New York, agreed to pay $65,000 to resolve allegations that it failed to comply with the Controlled Substances Act (CSA). United States Attorney Carla B. Freedman and Special Agent in Charge Frank...
PRESS RELEASE

Federal and State Law Enforcement Warn of Increased Threats Related to Fentanyl

DENVER - An influx of substances, more potent and deadlier than ever, are being seized in Colorado in record amounts. Fentanyl pills in all colors, shapes and sizes; fentanyl in liquid and powder form; and fentanyl adulterated with Xylazine are leading to an increased number of drug poisonings and overdoses...

Paginación

  • Primera página «
  • Anterior
  • Page 22
  • Page 23
  • Page 24
  • Page 25
  • Current page 26
  • Page 27
  • Page 28
  • Page 29
  • Page 30
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster